0.29% 0.05

Dopo l'orario di chiusura: 17.21 0.13 +0.76%

Teva Pharmaceutical Industries Ltd Adr (TEVA)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché TEVA Giù? Forum Previsione Frazionamento azionario Storia dei dividendi

Teva Pharmaceutical Industries Ltd Adr (TEVA)

Teva Pharmaceutical Industries Ltd Adr Borsa (TEVA) Ultime notizie

Such Is The Power Of CNH Industrial NV (NYSE: CNH) - Stocks Register

Zollinger-Ellison Syndrome (Gastrinoma) Global Clinical Trials Review 2024: Country (G7 & E7), Phase, Trial Status, End Points Status and Sponsor Type - GlobeNewswire Inc.

Where Do Analysts See Teva- Pharmaceutical Industries Ltd. ADR (NYSE: TEVA) Heading? - Stocks Register

Biliary Tract Cancer Market Research Report 2024-2030 with Analyst Recommendations - GlobeNewswire Inc.

South Africa Central Nervous System Therapeutic Market Size & Outlook, 2028 - Grand View Research

Spain Head And Neck Cancer Therapeutics Market Size & Outlook, 2030 - Grand View Research

Vontobel Holding Ltd. Sells 332,717 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA) - MarketBeat

Teva- Pharmaceutical Industries Ltd. ADR [TEVA] Is Currently 5.28 below its 200 Period Moving Avg: What Does This Mean? – The DBT News - The DBT News

Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Stock: The Story of a 52-Week Stock Range - The InvestChronicle

Ophthalmic Disease Therapeutics Market Analysis by Age-related Macular Degeneration, Diabetic Macular Edema, & Other Retinal Disorders - GlobeNewswire Inc.

Weekly Upgrades and Downgrades - InvestorPlace

Monitoring Teva- Pharmaceutical Industries Ltd. ADR (TEVA) after recent insider movements - Knox Daily

Views of Wall Street’s Leading Experts on Teva- Pharmaceutical Industries Ltd. ADR - SETE News

Selling Buzz: Teva- Pharmaceutical Industries Ltd. ADR [TEVA] Exec. VP, European Commercial Daniell Richard sells 98,943 shares of the company – Knox Daily - Knox Daily

Qifu Technology Inc. ADR (QFIN) gets rating Initiated from Nomura - Knox Daily

Teva- Pharmaceutical Industries Ltd. ADR [TEVA] Is Currently 1.45 below its 200 Period Moving Avg: What Does This Mean? – The DBT News - The DBT News

Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Stock: Exploring a Year of Highs, Lows, and Trading Volume - The InvestChronicle

Keeping an Eye on Teva- Pharmaceutical Industries Ltd. ADR (TEVA) After Insider Trading Activity - Knox Daily

TEVA’s current quarter earnings: What analysts forecast? - US Post News

Taking a look at what insiders are doing to gauge the Teva- Pharmaceutical Industries Ltd. ADR (TEVA)’s direction - Knox Daily

HP Stock Sees Surge of Approximately 3.50% in Last Five Days - Knox Daily

RPM International, Inc. [RPM] Shares Rise 6.30 % on Wednesday - Knox Daily

Alight Inc. (ALIT) gets rating Downgrade from JP Morgan - Knox Daily

TEVA’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle

Keycorp (NYSE: KEY) Up 50.91% This Year: What Is Going To Happen Next - Stocks Register

Argus upgrades Teva- Pharmaceutical Industries Ltd. ADR (TEVA) rating to a Buy - Knox Daily

TE Connectivity Ltd’s latest rating changes from various analysts - Knox Daily

FTCI’s latest rating updates from top analysts. - Knox Daily

Teva- Pharmaceutical Industries Ltd. ADR (TEVA): Worth A Small Bite At $17.54 - Stocks Register

How will Teva- Pharmaceutical Industries Ltd. ADR’s (TEVA) earnings compare to estimates this quarter? - US Post News

Teva- Pharmaceutical Industries Ltd. ADR [TEVA] Shares Jump Approximately 70.34% Over the Year - Knox Daily

Before You Invest, Make Sure You Check This New Oriental Education & Technology Group Inc. ADR (NYSE: EDU) Analysis – Stocks Register - Stocks Register

TEVA’s Market Flip-Flop: Exploring the Volatility of 2023 Performance - The InvestChronicle

Does Walmart Inc (NYSE: WMT) Still Need To Convince Analysts? - Stocks Register

When Would Be The Best Time To Buy UiPath Inc (NYSE: PATH) Stock? - Stocks Register

Teva- Pharmaceutical Industries Ltd. ADR [TEVA] Stock trading around $17.72 per share: What’s Next? - The DBT News

Checking in on Teva- Pharmaceutical Industries Ltd. ADR (TEVA) after recent insiders movement - Knox Daily

New Data Provide Treatment Insights into Options for Switching Adult Patients Diagnosed with Schizophrenia to UZEDY (risperidone) Extended-Release Injectable Suspension from Perseris (RBP-7000) - wallstreet:online

DLTR Shares Experience Surge in Value - Knox Daily

A company insider recently sold 708 shares of NAPCO Security Technologies Inc [NSSC]. Should You Sale? - Knox Daily

TEVA Shares Experience Surge in Value - Knox Daily

Does Teva- Pharmaceutical Industries Ltd. ADR (TEVA) offer a good opportunity for investors? - SETE News

How analysts predict Teva- Pharmaceutical Industries Ltd. ADR (TEVA) will perform this quarter? - US Post News

Argus analysts upgrades a Buy rating for Teva- Pharmaceutical Industries Ltd. ADR (TEVA) - Knox Daily

Teva- Pharmaceutical Industries Ltd. ADR Inc. (TEVA) Price Performance: The Role of Share Buybacks and Stock Splits - The InvestChronicle

What will the future hold for Teva- Pharmaceutical Industries Ltd. ADR (NYSE:TEVA) stock? - US Post News

Insider Selling: Daniell Richard, Teva- Pharmaceutical Industries Ltd. ADR [TEVA] Exec. VP, European Commercial divested 98,943 shares – Knox Daily - Knox Daily

insider CHURAY DANIEL J sale 16,975 shares of MRC Global Inc [MRC] - Knox Daily

The United States Erythropoietin Drugs Market Size & Outlook, 2030 - Grand View Research

Simile a TEVA